Cefadroxil Capsule
NDC 72189-445
Product Information
Cefadroxil is a ANDA-approved product labeled by Direct_rx. This medication is used to treat a wide variety of bacterial infections. It is supplied as a white capsule for oral administration. This product entry covers the primary NDC 72189-445 and 2 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
RED (C48326 - (MAROON CAP))
LU;F11
Code Structure Chart
Product Details
What is NDC 72189-445?
What are the uses of this product?
What are Active Ingredients of this product?
- CEFADROXIL 500 mg/1 - Long-acting, broad-spectrum, water-soluble, CEPHALEXIN derivative.
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- CEFADROXIL (UNII: 280111G160)
- CEFADROXIL ANHYDROUS (UNII: Q525PA8JJB) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- FD&C RED NO. 40 (UNII: WZB9127XOA)
- PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
- FERROSOFERRIC OXIDE (UNII: XM0M87F357)
- D&C RED NO. 28 (UNII: 767IP0Y5NH)
- FD&C BLUE NO. 1 (UNII: H3R47K3TBD)
- GELATIN (UNII: 2G86QN327L)
- CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
- SHELLAC (UNII: 46N107B71O)
- POTASSIUM HYDROXIDE (UNII: WZH3C48M4T)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
- CROSPOVIDONE (UNII: 2S7830E561)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 309049 - cefadroxil 500 MG Oral Capsule
- RxCUI: 309049 - cefadroxil (as cefadroxil monohydrate) 500 MG Oral Capsule
Which are the Pharmacologic Classes of this product?
* Please review the full disclaimer at the bottom of this page.